European journal of nuclear medicine and molecular imaging 48 (2021): S421–S422. doi:10.1007/s00259-021-05547-1 info:cnr-pdr/source/autori:Valtorta S.; Chiu M.; Toscani D.; Sartori A.; Coliva A.; Brevi A.; Taurino G.; Grioni M.; Ruffini L.; Vacondio F.; Zanardi F.; Bellone M.; Moresco R.R.; Bussolati O.; Giuliani N./titolo:Validation of [18F]-(2S,4R)-4-Fluoroglutamine in Multiple Myeloma Mouse Models/doi:10.1007%2Fs00259-021-05547-1/rivista:European journal of nuclear medicine and molecular imaging (Print)/anno:2021/pagina_da:S421/pagina_a:S422/intervallo_pagine:S421–S422/volume:48
European journal of nuclear medicine and molecular imaging 48 (2021): S252–S252. doi:10.1007/s00259-021-05547-1 info:cnr-pdr/source/autori:Rainone P.; Valtorta S.; Todde S.; Salvatore R.; Moresco R.M./titolo:The evaluation of [18F]FDG and [18F]FLT radiotracers as potential biomarkers of early treatment outcome in triple negative breast cancer (TNBC)/doi:10.1007%2Fs00259-021-05547-1/rivista:European journal of nuclear medicine and molecular imaging (Print)/anno:2021/pagina_da:S252/pagina_a:S252/intervallo_pagine:S252–S252/volume:48